Status:
COMPLETED
Epigenetics in PostOperative Pediatric Emergence Delirium
Lead Sponsor:
University of Sao Paulo
Conditions:
Emergence Delirium
Postoperative Complications
Eligibility:
All Genders
1-12 years
Phase:
NA
Brief Summary
Emergence delirium (ED) infers the occurrence of behavior and cognition changes during the early postoperative period. Main signs and symptoms of ED are the disturbances of consciousness and awareness...
Detailed Description
BACKGROUND: The risks of neurotoxicity and late cognitive impairment supported the recent US Food and Drug Administration (FDA) recommendation on caution in the indication of anesthesia in children up...
Eligibility Criteria
Inclusion
- children with ASA physical status 1, 2 or 3
Exclusion
- children under psychiatric medication
- developmental delays
- genetics syndromes that course with developmental delays
- contraindication to randomization
Key Trial Info
Start Date :
September 24 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
175 Patients enrolled
Trial Details
Trial ID
NCT03787849
Start Date
September 24 2018
End Date
December 31 2021
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto da Criança do Hospital das Clinicas da FMUSP
São Paulo, Brazil